EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mechanically Triggered DNA Nanovehicles for Targeted Dual‐Drug Cancer Therapy

Murali Mohana Rao Singuru iD, Priyanka Bhattacharyya, Mingxu You iD

Advanced Science · 2026

DOI: 10.1002/advs.75286 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Murali Mohana Rao Singuru und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Massachusetts Amherst, Amherst, Massachusetts, USA. Hauptthemen laut MEDLINE: Drug Delivery Systems, Doxorubicin, Antineoplastic Agents, DNA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, National Science Foundation, Camille Dreyfus Teacher-Scholar Award.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Stimuli‐responsive dual‐drug delivery systems enable precise therapeutic control by co‐releasing multiple agents, enhancing synergy while reducing dosage and side effects. Mechanical dysregulation is a hallmark of various diseases, yet force‐responsive platforms remain rare. Here, we introduce a DNA‐based mechanical nanovehicle that releases two anticancer drugs—TMPyP4 and doxorubicin—in response to tensile forces generated by integrin receptors at cell–cell junctions. The cholesterol‐modified DNA constructs anchor to the cell membrane and undergoes force‐induced structural changes, triggering rapid drug release under defined mechanical conditions. Our studies demonstrated selective activation in HeLa and MCF‐7 cancer cells, achieving potent cytotoxicity while minimizing off‐target effects in low‐tension HEK293T cells. This modular platform integrates mechanosensing, real‐time force visualization, and targeted therapy, establishing a new class of mechanoresponsive dual‐drug delivery systems for safer and more effective cancer treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Delivery SystemsDoxorubicinAntineoplastic AgentsDNANeoplasmsHumansDNA NanostructuresHeLa CellsMCF-7 Cells

Stichwörter der Autor:innen

DNA nanovehicledual‐drug deliveryintegrin‐mediated forcesintercellular forcestargeted cancer therapy

Substanzen

DoxorubicinAntineoplastic AgentsDNA

Autor:innen und Institutionen

  • Department of Chemistry, University of Massachusetts Amherst, Amherst, Massachusetts, USA.
  • Molecular and Cellular Biology Graduate Program, University of Massachusetts Amherst, Amherst, Massachusetts, USA.

ORCID-Profile: Murali Mohana Rao Singuru, Mingxu You

Förderung

  • NIGMS NIH HHS
  • National Science Foundation
  • Camille Dreyfus Teacher-Scholar Award
  • National Institute of General Medical Sciences

Zitieren

APA

Singuru, M. M. R., Bhattacharyya, P., & You, M. (2026). Mechanically Triggered DNA Nanovehicles for Targeted Dual‐Drug Cancer Therapy. Advanced Science. https://doi.org/10.1002/advs.75286

Vancouver

Singuru MMR, Bhattacharyya P, You M. Mechanically Triggered DNA Nanovehicles for Targeted Dual‐Drug Cancer Therapy. Advanced Science. 2026. doi:10.1002/advs.75286

BibTeX
@article{Singuru2026,
  author = {Singuru, Murali Mohana Rao and Bhattacharyya, Priyanka and You, Mingxu},
  title = {Mechanically Triggered DNA Nanovehicles for Targeted Dual‐Drug Cancer Therapy},
  journal = {Advanced Science},
  year = {2026},
  doi = {10.1002/advs.75286}
}
Kostenlos starten →